RECURRENT NON-SMALL CELL LUNG CANCER
Clinical trials for RECURRENT NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for RECURRENT NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink lung tumors better than current standard
Disease control OngoingThis study tests whether adding a new immunotherapy drug (relatlimab) to the usual nivolumab-plus-chemotherapy treatment can shrink tumors more effectively in people with advanced or recurrent non-small cell lung cancer. About 468 participants will receive either the three-drug c…
Matched conditions: RECURRENT NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
Precision radiation boost shows promise for tough lung cancers
Disease control OngoingThis study tested a new way of giving radiation therapy (called image-guided hypofractionated radiotherapy with a stereotactic boost) along with standard chemotherapy for people with stage II-III non-small cell lung cancer that cannot be removed by surgery. The goal was to find t…
Matched conditions: RECURRENT NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:03 UTC